THERAVANCE BIOPHARMA, INC. Reports Q2 2025 Financial Results

2025-08-13SEC Filing 10-Q (0001558370-25-011408)

Please check the link below for details.

Tickers mentioned in this filing:TBPH

The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1583107/0001558370-25-011408.txt